Dr. Emmalie Schoepke is responsible for demonstrating the CellRaft® AIR System to the scientific community, training current customers, and troubleshooting novel workflows. Her background is in Nuclear Receptor pharmacology, testing novel drugs in 2D and 3D cell-based assays. She received post-doctoral training in translational breast cancer research at Baylor College of Medicine, obtained a Ph.D. in Pharmacology and Physiology from Saint Louis University, and holds a Bachelor of Science in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign.